Targeting a market Big Pharma's fleeing, Tetraphase wins FDA nod for antibiotic Xerava
admin 28th August 2018 Uncategorised 0Just as Big Pharmas are bailing out of antibiotics research left and right, a small biotech is pressing ahead. Tetraphase Pharmaceuticals snagged an FDA nod Monday for Xerava, an infection-fighter engineered to overcome drug resistance.
More: Targeting a market Big Pharma's fleeing, Tetraphase wins FDA nod for antibiotic Xerava
Source: fierce